Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ..
BACKGROUND: Faecal Prevotellaceae, and other microbes, have been associated with rheumatoid arthritis (RA) and preclinical RA. We have performed a quantitative microbiome profiling study in preclinical stages of RA.
METHODS: First-degree relatives of patients with RA (RA-FDRs) from the SCREEN-RA cohort were categorised into four groups: controls, healthy asymptomatic RA-FDRs; high genetic risk, asymptomatic RA-FDRs with two copies of the shared epitope; autoimmunity, asymptomatic RA-FDRs with RA-associated autoimmunity; and symptomatic, clinically suspect arthralgias or untreated new-onset RA.Faecal samples were collected and frozen. 16S sequencing was performed, processed with DADA2 pipeline and Silva database. Cell counts (cytometry) and faecal calprotectin (enzyme-linked immunosorbent assay, ELISA) were also obtained. Microbial community analyses were conducted using non-parametric tests, such as permutational multivariate analysis of variance (PERMANOVA), Wilcoxon and Kruskal-Wallis, or Aldex2.
RESULTS: A total of 371 individuals were included and categorised according to their preclinical stage of the disease. Groups had similar age, gender and body mass index. We found no significant differences in the quantitative microbiome profiles by preclinical stages (PERMANOVA, R2=0.00798, p=0.56) and, in particular, no group differences in Prevotellaceae abundance. Results were similar when using relative microbiome profiling data (PERMANOVA, R2=0.0073, p=0.83) or Aldex2 on 16S sequence counts. Regarding faecal calprotectin, we found no differences between groups (p=0.3).
CONCLUSIONS: We could not identify microbiome profiles associated with preclinical stages of RA. Only in a subgroup of individuals with the most pronounced phenotypes did we modestly retrieve the previously reported associations.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
RMD open - 10(2024), 1 vom: 30. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gilbert, Benoît Thomas P [VerfasserIn] |
---|
Links: |
---|
Themen: |
Autoantibodies |
---|
Anmerkungen: |
Date Completed 05.02.2024 Date Revised 05.02.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/rmdopen-2023-003589 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367980096 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367980096 | ||
003 | DE-627 | ||
005 | 20240205232105.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240204s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/rmdopen-2023-003589 |2 doi | |
028 | 5 | 2 | |a pubmed24n1281.xml |
035 | |a (DE-627)NLM367980096 | ||
035 | |a (NLM)38296308 | ||
035 | |a (PII)e003589 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gilbert, Benoît Thomas P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.02.2024 | ||
500 | |a Date Revised 05.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. | ||
520 | |a BACKGROUND: Faecal Prevotellaceae, and other microbes, have been associated with rheumatoid arthritis (RA) and preclinical RA. We have performed a quantitative microbiome profiling study in preclinical stages of RA | ||
520 | |a METHODS: First-degree relatives of patients with RA (RA-FDRs) from the SCREEN-RA cohort were categorised into four groups: controls, healthy asymptomatic RA-FDRs; high genetic risk, asymptomatic RA-FDRs with two copies of the shared epitope; autoimmunity, asymptomatic RA-FDRs with RA-associated autoimmunity; and symptomatic, clinically suspect arthralgias or untreated new-onset RA.Faecal samples were collected and frozen. 16S sequencing was performed, processed with DADA2 pipeline and Silva database. Cell counts (cytometry) and faecal calprotectin (enzyme-linked immunosorbent assay, ELISA) were also obtained. Microbial community analyses were conducted using non-parametric tests, such as permutational multivariate analysis of variance (PERMANOVA), Wilcoxon and Kruskal-Wallis, or Aldex2 | ||
520 | |a RESULTS: A total of 371 individuals were included and categorised according to their preclinical stage of the disease. Groups had similar age, gender and body mass index. We found no significant differences in the quantitative microbiome profiles by preclinical stages (PERMANOVA, R2=0.00798, p=0.56) and, in particular, no group differences in Prevotellaceae abundance. Results were similar when using relative microbiome profiling data (PERMANOVA, R2=0.0073, p=0.83) or Aldex2 on 16S sequence counts. Regarding faecal calprotectin, we found no differences between groups (p=0.3) | ||
520 | |a CONCLUSIONS: We could not identify microbiome profiles associated with preclinical stages of RA. Only in a subgroup of individuals with the most pronounced phenotypes did we modestly retrieve the previously reported associations | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Autoimmune Diseases | |
650 | 4 | |a Autoimmunity | |
650 | 4 | |a Permeability | |
650 | 4 | |a Rheumatoid Arthritis | |
650 | 4 | |a Rheumatoid Factor | |
650 | 7 | |a Autoantibodies |2 NLM | |
650 | 7 | |a Leukocyte L1 Antigen Complex |2 NLM | |
700 | 1 | |a Tadeo, Raul Yhossef Tito |e verfasserin |4 aut | |
700 | 1 | |a Lamacchia, Celine |e verfasserin |4 aut | |
700 | 1 | |a Studer, Olivia |e verfasserin |4 aut | |
700 | 1 | |a Courvoisier, Delphine |e verfasserin |4 aut | |
700 | 1 | |a Raes, Jeroen |e verfasserin |4 aut | |
700 | 1 | |a Finckh, Axel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t RMD open |d 2015 |g 10(2024), 1 vom: 30. Jan. |w (DE-627)NLM254089658 |x 2056-5933 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2024 |g number:1 |g day:30 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/rmdopen-2023-003589 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2024 |e 1 |b 30 |c 01 |